A retrospective study suggests that semaglutide is not associated with increased risk for non-arteritic anterior ischemic optic neuropathy (NAION).

Black patients were less likely to have conclusive genetic testing compared to White patients when screening for inherited retinal diseases.

Sodium-glucose co-transporter 2 inhibitors were shown to decrease risk of glaucoma compared to other antihyperglycemic agents.